1. Home
  2. HLIT vs NTLA Comparison

HLIT vs NTLA Comparison

Compare HLIT & NTLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Harmonic Inc.

HLIT

Harmonic Inc.

HOLD

Current Price

$11.78

Market Cap

1.5B

Sector

Technology

ML Signal

HOLD

Logo Intellia Therapeutics Inc.

NTLA

Intellia Therapeutics Inc.

N/A

Current Price

$12.74

Market Cap

1.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HLIT
NTLA
Founded
1988
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.8B
IPO Year
1996
2016

Fundamental Metrics

Financial Performance
Metric
HLIT
NTLA
Price
$11.78
$12.74
Analyst Decision
Buy
Buy
Analyst Count
4
23
Target Price
$14.67
$20.02
AVG Volume (30 Days)
1.5M
3.1M
Earning Date
05-11-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
27.43
EPS
0.05
N/A
Revenue
N/A
$67,671,000.00
Revenue This Year
$42.73
N/A
Revenue Next Year
$18.36
$62.75
P/E Ratio
$233.20
N/A
Revenue Growth
N/A
16.92
52 Week Low
$8.47
$7.95
52 Week High
$17.68
$28.24

Technical Indicators

Market Signals
Indicator
HLIT
NTLA
Relative Strength Index (RSI) 42.45 51.41
Support Level $11.38 $12.55
Resistance Level $12.48 $13.88
Average True Range (ATR) 0.39 0.66
MACD -0.06 0.06
Stochastic Oscillator 5.83 53.28

Price Performance

Historical Comparison
HLIT
NTLA

About HLIT Harmonic Inc.

Harmonic Inc engaged in broadband access solutions that enable broadband operators to more efficiently and effectively deploy high-speed internet for data, voice, and video services for their customers and versatile and high-performance video delivery software, products, system solutions and services that enable its customers to efficiently create, prepare, store, playout and deliver a full range of high-quality broadcast and streaming video services to consumer devices, including televisions, personal computers, laptops, tablets, and smartphones. It has two segments, Broadband which provides broadband access solutions and related services, and Others; and Video business provides video processing and production and playout solutions and services, and Others.

About NTLA Intellia Therapeutics Inc.

Intellia Therapeutics is a gene-editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis.

Share on Social Networks: